SAB Biotherapeutics, Inc.

SABSNASDAQ Global Market·USD·Closed

SABSNASDAQ·USD·Closed

$3.32

−4.29%

$3.32

−$0.15 (4.29%)

52W Range

34thpctl

Volume

0.07×avg

Mkt Cap

31.74MUSD

P/E

-447.6TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

34thpctl

Volume

0.07×avg

Market Cap

31.74MUSD

P/E Ratio

-447.6TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-24.3%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-248.8×

Current ratio11.45×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required